<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01545739</url>
  </required_header>
  <id_info>
    <org_study_id>57</org_study_id>
    <nct_id>NCT01545739</nct_id>
  </id_info>
  <brief_title>Evia/Entovis HF-T Master Study</brief_title>
  <official_title>Master Study of the Evia/Entovis HF-T Pacemaker</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Evia HF-T and the Entovis HF-T are triple-chamber pacemakers for cardiac
      resynchronisation therapy (CRT-P). The objective of this study is to prove the safety and
      efficacy of these pacemakers. In particular, the left ventricular (LV) capture control
      feature is evaluated, which automatically measures the LV pacing threshold and subsequently
      adjusts the pacing output.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Safety: Serious Adverse Device Effect (SADE) free rate</measure>
    <time_frame>Until 3 month follow-up</time_frame>
    <description>While the investigator is asked to record all adverse events throughout the study, only the number of SADEs possibly or securely related to a device deficiency will be the basis for the calculation of the SADE free rate: (1-number of SADE divided by number of patients)%.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy of the left ventricular capture control feature (focus on threshold measurements)</measure>
    <time_frame>At pre-hospital discharge, 1 and 3 month follow-up</time_frame>
    <description>Absolute difference between the triggered automatic and manual pacing threshold in the left ventricle is smaller than 0.3 Volt.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy of the left ventricular capture control feature (focus on pulse amplitude adjustment)</measure>
    <time_frame>1 and 3 month follow-up</time_frame>
    <description>Rate of appropriate adjustment of the left ventricular (LV) pulse amplitude by the LV capture control feature is greater than 90%.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">122</enrollment>
  <condition>Indication for Cardiac Resynchronization Therapy (CRT)</condition>
  <arm_group>
    <arm_group_label>CRT pacemaker implantation</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Evia/Entovis HF-T pacemaker for CRT therapy</intervention_name>
    <description>Implantation of CRT pacemaker and standard follow-ups at pre-hospital discharge, and after 1, 3 and 6 months</description>
    <arm_group_label>CRT pacemaker implantation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with indication for CRT therapy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Standard indication for CRT therapy

          -  Legal capacity and ability to consent

          -  Signed patient informed consent

        Exclusion Criteria:

          -  Contraindication for CRT therapy

          -  ICD indication

          -  Age &lt; 18 years

          -  Pregnant or breast-feeding woman

          -  Cardiac surgery planned within the next 6 months

          -  Life expectancy of less than 6 months

          -  Participating in another clinical study of an investigational cardiac drug or device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Semmelweis University</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2012</study_first_submitted>
  <study_first_submitted_qc>March 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2012</study_first_posted>
  <last_update_submitted>October 15, 2014</last_update_submitted>
  <last_update_submitted_qc>October 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pacemaker therapy</keyword>
  <keyword>Cardiac resynchronisation therapy (CRT)</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

